APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Animal Antibacterial and Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Animal Antibacterial and Antibiotics Market Analysis and Forecast 2026-2032

Report ID 173963770220 December 2025206 pages

Choose your research edition.

Industry ResearchAnimal Antibacterial and Antibiotics Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Antibacterial and Antibiotics Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Animal Antibacterial and Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Antibacterial and Antibiotics Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Antibacterial and Antibiotics Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Animal Antibacterial and Antibiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Animal Antibacterial and Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Animal Antibacterial and Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Animal Antibacterial and Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Animal Antibacterial and Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Animal Antibacterial and Antibiotics include Biogénesis Bagó, Boehringer Ingelheim Vetmedica, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Elanco, Huvepharma, Merial and Neogen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Animal Antibacterial and Antibiotics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Antibacterial and Antibiotics, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Antibacterial and Antibiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Antibacterial and Antibiotics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Antibacterial and Antibiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Antibacterial and Antibiotics revenue, projected growth trends, production technology, application and end-user industry.

Animal Antibacterial and Antibiotics Segment by Company

Biogénesis Bagó

Boehringer Ingelheim Vetmedica

Ceva Santé Animale

Dechra Pharmaceuticals

ECO Animal Health

Elanco

Huvepharma

Merial

Neogen

Norbrook

Orion

Phibro Animal Health

Vétoquinol

Virbac

Vitafor

Bayer HealthCare

Merck Animal Health

Zoetis

Animal Antibacterial and Antibiotics Segment by Type

Cephalosporins

Tetracyclines

Penicillins

Sulfonamides

Macrolides

Aminoglycosides

Animal Antibacterial and Antibiotics Segment by Application

Livestock

Pets

Others

Animal Antibacterial and Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Antibacterial and Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Antibacterial and Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Antibacterial and Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Animal Antibacterial and Antibiotics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Animal Antibacterial and Antibiotics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Antibacterial and Antibiotics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cephalosporins Major Player Table 3. Tetracyclines Major Player Table 4. Penicillins Major Player Table 5. Sulfonamides Major Player Table 6. Macrolides Major Player Table 7. Aminoglycosides Major Player Table 8. Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Livestock Major Player Table 10. Pets Major Player Table 11. Others Major Player Table 12. Animal Antibacterial and Antibiotics Industry Trends Table 13. Animal Antibacterial and Antibiotics Industry Drivers Table 14. Animal Antibacterial and Antibiotics Industry Opportunities and Challenges Table 15. Animal Antibacterial and Antibiotics Industry Restraints Table 16. Global Animal Antibacterial and Antibiotics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Animal Antibacterial and Antibiotics Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Animal Antibacterial and Antibiotics Market Share by Region (2021-2026) Table 19. Global Animal Antibacterial and Antibiotics Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Animal Antibacterial and Antibiotics Market Share by Region (2027-2032) Table 21. Global Animal Antibacterial and Antibiotics Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Animal Antibacterial and Antibiotics Revenue Market Share by Players (2021-2026) Table 23. Global Animal Antibacterial and Antibiotics Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Animal Antibacterial and Antibiotics Key Players Headquarters & Area Served Table 25. Global Animal Antibacterial and Antibiotics Players, Product Type & Application Table 26. Global Animal Antibacterial and Antibiotics Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Animal Antibacterial and Antibiotics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Animal Antibacterial and Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Animal Antibacterial and Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Animal Antibacterial and Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Animal Antibacterial and Antibiotics Revenue Market Share by Type (2021-2026) Table 33. Global Animal Antibacterial and Antibiotics Revenue Market Share by Type (2027-2032) Table 34. Global Animal Antibacterial and Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Animal Antibacterial and Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Animal Antibacterial and Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2021-2026) Table 38. Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2027-2032) Table 39. Biogénesis Bagó Company Information Table 40. Biogénesis Bagó Business Overview Table 41. Biogénesis Bagó Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Biogénesis Bagó Animal Antibacterial and Antibiotics Product Portfolio Table 43. Biogénesis Bagó Recent Development Table 44. Boehringer Ingelheim Vetmedica Company Information Table 45. Boehringer Ingelheim Vetmedica Business Overview Table 46. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Product Portfolio Table 48. Boehringer Ingelheim Vetmedica Recent Development Table 49. Ceva Santé Animale Company Information Table 50. Ceva Santé Animale Business Overview Table 51. Ceva Santé Animale Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Ceva Santé Animale Animal Antibacterial and Antibiotics Product Portfolio Table 53. Ceva Santé Animale Recent Development Table 54. Dechra Pharmaceuticals Company Information Table 55. Dechra Pharmaceuticals Business Overview Table 56. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Product Portfolio Table 58. Dechra Pharmaceuticals Recent Development Table 59. ECO Animal Health Company Information Table 60. ECO Animal Health Business Overview Table 61. ECO Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. ECO Animal Health Animal Antibacterial and Antibiotics Product Portfolio Table 63. ECO Animal Health Recent Development Table 64. Elanco Company Information Table 65. Elanco Business Overview Table 66. Elanco Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Elanco Animal Antibacterial and Antibiotics Product Portfolio Table 68. Elanco Recent Development Table 69. Huvepharma Company Information Table 70. Huvepharma Business Overview Table 71. Huvepharma Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Huvepharma Animal Antibacterial and Antibiotics Product Portfolio Table 73. Huvepharma Recent Development Table 74. Merial Company Information Table 75. Merial Business Overview Table 76. Merial Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Merial Animal Antibacterial and Antibiotics Product Portfolio Table 78. Merial Recent Development Table 79. Neogen Company Information Table 80. Neogen Business Overview Table 81. Neogen Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Neogen Animal Antibacterial and Antibiotics Product Portfolio Table 83. Neogen Recent Development Table 84. Norbrook Company Information Table 85. Norbrook Business Overview Table 86. Norbrook Animal Antibacterial and Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Norbrook Animal Antibacterial and Antibiotics Product Portfolio Table 88. Norbrook Recent Development Table 89. Orion Company Information Table 90. Orion Business Overview Table 91. Orion Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Orion Animal Antibacterial and Antibiotics Product Portfolio Table 93. Orion Recent Development Table 94. Phibro Animal Health Company Information Table 95. Phibro Animal Health Business Overview Table 96. Phibro Animal Health Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Phibro Animal Health Animal Antibacterial and Antibiotics Product Portfolio Table 98. Phibro Animal Health Recent Development Table 99. Vétoquinol Company Information Table 100. Vétoquinol Business Overview Table 101. Vétoquinol Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Vétoquinol Animal Antibacterial and Antibiotics Product Portfolio Table 103. Vétoquinol Recent Development Table 104. Virbac Company Information Table 105. Virbac Business Overview Table 106. Virbac Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Virbac Animal Antibacterial and Antibiotics Product Portfolio Table 108. Virbac Recent Development Table 109. Vitafor Company Information Table 110. Vitafor Business Overview Table 111. Vitafor Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Vitafor Animal Antibacterial and Antibiotics Product Portfolio Table 113. Vitafor Recent Development Table 114. Bayer HealthCare Company Information Table 115. Bayer HealthCare Business Overview Table 116. Bayer HealthCare Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Bayer HealthCare Animal Antibacterial and Antibiotics Product Portfolio Table 118. Bayer HealthCare Recent Development Table 119. Merck Animal Health Company Information Table 120. Merck Animal Health Business Overview Table 121. Merck Animal Health Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Merck Animal Health Animal Antibacterial and Antibiotics Product Portfolio Table 123. Merck Animal Health Recent Development Table 124. Zoetis Company Information Table 125. Zoetis Business Overview Table 126. Zoetis Animal Antibacterial and Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Zoetis Animal Antibacterial and Antibiotics Product Portfolio Table 128. Zoetis Recent Development Table 129. North America Animal Antibacterial and Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Animal Antibacterial and Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Animal Antibacterial and Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Animal Antibacterial and Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Animal Antibacterial and Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 135. North America Animal Antibacterial and Antibiotics Revenue by Country (US$ Million) & (2027-2032) Table 136. Europe Animal Antibacterial and Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Animal Antibacterial and Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Animal Antibacterial and Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Animal Antibacterial and Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Animal Antibacterial and Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 142. Europe Animal Antibacterial and Antibiotics Revenue by Country (US$ Million) & (2027-2032) Table 143. China Animal Antibacterial and Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 144. China Animal Antibacterial and Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 145. China Animal Antibacterial and Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 146. China Animal Antibacterial and Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Animal Antibacterial and Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Animal Antibacterial and Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Animal Antibacterial and Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Animal Antibacterial and Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Animal Antibacterial and Antibiotics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Animal Antibacterial and Antibiotics Revenue by Region (US$ Million) & (2021-2026) Table 153. Asia Animal Antibacterial and Antibiotics Revenue by Region (US$ Million) & (2027-2032) Table 154. SAMEA Animal Antibacterial and Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Animal Antibacterial and Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Animal Antibacterial and Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 157. SAMEA Animal Antibacterial and Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 158. SAMEA Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Animal Antibacterial and Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 160. SAMEA Animal Antibacterial and Antibiotics Revenue by Country (US$ Million) & (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Animal Antibacterial and Antibiotics Image Figure 2. Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Antibacterial and Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cephalosporins Image Figure 5. Tetracyclines Image Figure 6. Penicillins Image Figure 7. Sulfonamides Image Figure 8. Macrolides Image Figure 9. Aminoglycosides Image Figure 10. Global Animal Antibacterial and Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Animal Antibacterial and Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 12. Livestock Image Figure 13. Pets Image Figure 14. Others Image Figure 15. Global Animal Antibacterial and Antibiotics Market Size (US$ Million) & (2021-2032) Figure 16. Global Animal Antibacterial and Antibiotics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Animal Antibacterial and Antibiotics Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Animal Antibacterial and Antibiotics Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Animal Antibacterial and Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Animal Antibacterial and Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Animal Antibacterial and Antibiotics Revenue Market Share by Type (2021-2032) Figure 23. Global Animal Antibacterial and Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2021-2032) Figure 26. North America Animal Antibacterial and Antibiotics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032) Figure 28. North America Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032) Figure 29. North America Animal Antibacterial and Antibiotics Revenue Share by Country (2021-2032) Figure 30. United States Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Animal Antibacterial and Antibiotics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032) Figure 35. Europe Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032) Figure 36. Europe Animal Antibacterial and Antibiotics Revenue Share by Country (2021-2032) Figure 37. Germany Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Animal Antibacterial and Antibiotics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032) Figure 47. China Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032) Figure 48. Asia Animal Antibacterial and Antibiotics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032) Figure 50. Asia Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032) Figure 51. Asia Animal Antibacterial and Antibiotics Revenue Share by Region (2021-2032) Figure 52. Japan Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Animal Antibacterial and Antibiotics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032) Figure 60. SAMEA Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032) Figure 61. SAMEA Animal Antibacterial and Antibiotics Revenue Share by Country (2021-2032) Figure 62. Brazil Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Animal Antibacterial and Antibiotics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporins
  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
Applications
  • Livestock
  • Pets
  • Others
Companies covered
  • Biogénesis Bagó
  • Boehringer Ingelheim Vetmedica
  • Ceva Santé Animale
  • Dechra Pharmaceuticals
  • ECO Animal Health
  • Elanco
  • Huvepharma
  • Merial
  • Neogen
  • Norbrook
  • Orion
  • Phibro Animal Health
  • Vétoquinol
  • Virbac
  • Vitafor
  • Bayer HealthCare
  • Merck Animal Health
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Antibacterial and Antibiotics Market by Type
  3. 1.2.1 Global Animal Antibacterial and Antibiotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cephalosporins
  5. 1.2.3 Tetracyclines
  6. 1.2.4 Penicillins
  7. 1.2.5 Sulfonamides
  8. 1.2.6 Macrolides
  9. 1.2.7 Aminoglycosides
  10. 1.3 Animal Antibacterial and Antibiotics Market by Application
  11. 1.3.1 Global Animal Antibacterial and Antibiotics Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Livestock
  13. 1.3.3 Pets
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Animal Antibacterial and Antibiotics Market Dynamics
  1. 2.1 Animal Antibacterial and Antibiotics Industry Trends
  2. 2.2 Animal Antibacterial and Antibiotics Industry Drivers
  3. 2.3 Animal Antibacterial and Antibiotics Industry Opportunities and Challenges
  4. 2.4 Animal Antibacterial and Antibiotics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Animal Antibacterial and Antibiotics Market Perspective (2021-2032)
  2. 3.2 Global Animal Antibacterial and Antibiotics Growth Trends by Region
  3. 3.2.1 Global Animal Antibacterial and Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Antibacterial and Antibiotics Market Size by Region (2021-2026)
  5. 3.2.3 Global Animal Antibacterial and Antibiotics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Animal Antibacterial and Antibiotics Revenue by Players
  2. 4.1.1 Global Animal Antibacterial and Antibiotics Revenue by Players (2021-2026)
  3. 4.1.2 Global Animal Antibacterial and Antibiotics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Animal Antibacterial and Antibiotics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Antibacterial and Antibiotics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Animal Antibacterial and Antibiotics Key Players Headquarters & Area Served
  7. 4.4 Global Animal Antibacterial and Antibiotics Players, Product Type & Application
  8. 4.5 Global Animal Antibacterial and Antibiotics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Animal Antibacterial and Antibiotics Market CR5 and HHI
  11. 4.6.3 2025 Animal Antibacterial and Antibiotics Tier 1, Tier 2, and Tier 3
5 Animal Antibacterial and Antibiotics Market Size by Type
  1. 5.1 Global Animal Antibacterial and Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Animal Antibacterial and Antibiotics Revenue by Type (2021-2032)
  3. 5.3 Global Animal Antibacterial and Antibiotics Revenue Market Share by Type (2021-2032)
6 Animal Antibacterial and Antibiotics Market Size by Application
  1. 6.1 Global Animal Antibacterial and Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Animal Antibacterial and Antibiotics Revenue by Application (2021-2032)
  3. 6.3 Global Animal Antibacterial and Antibiotics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Biogénesis Bagó
  2. 7.1.1 Biogénesis Bagó Company Information
  3. 7.1.2 Biogénesis Bagó Business Overview
  4. 7.1.3 Biogénesis Bagó Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Biogénesis Bagó Animal Antibacterial and Antibiotics Product Portfolio
  6. 7.1.5 Biogénesis Bagó Recent Developments
  7. 7.2 Boehringer Ingelheim Vetmedica
  8. 7.2.1 Boehringer Ingelheim Vetmedica Company Information
  9. 7.2.2 Boehringer Ingelheim Vetmedica Business Overview
  10. 7.2.3 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Vetmedica Recent Developments
  13. 7.3 Ceva Santé Animale
  14. 7.3.1 Ceva Santé Animale Company Information
  15. 7.3.2 Ceva Santé Animale Business Overview
  16. 7.3.3 Ceva Santé Animale Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Ceva Santé Animale Animal Antibacterial and Antibiotics Product Portfolio
  18. 7.3.5 Ceva Santé Animale Recent Developments
  19. 7.4 Dechra Pharmaceuticals
  20. 7.4.1 Dechra Pharmaceuticals Company Information
  21. 7.4.2 Dechra Pharmaceuticals Business Overview
  22. 7.4.3 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Product Portfolio
  24. 7.4.5 Dechra Pharmaceuticals Recent Developments
  25. 7.5 ECO Animal Health
  26. 7.5.1 ECO Animal Health Company Information
  27. 7.5.2 ECO Animal Health Business Overview
  28. 7.5.3 ECO Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ECO Animal Health Animal Antibacterial and Antibiotics Product Portfolio
  30. 7.5.5 ECO Animal Health Recent Developments
  31. 7.6 Elanco
  32. 7.6.1 Elanco Company Information
  33. 7.6.2 Elanco Business Overview
  34. 7.6.3 Elanco Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Elanco Animal Antibacterial and Antibiotics Product Portfolio
  36. 7.6.5 Elanco Recent Developments
  37. 7.7 Huvepharma
  38. 7.7.1 Huvepharma Company Information
  39. 7.7.2 Huvepharma Business Overview
  40. 7.7.3 Huvepharma Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Huvepharma Animal Antibacterial and Antibiotics Product Portfolio
  42. 7.7.5 Huvepharma Recent Developments
  43. 7.8 Merial
  44. 7.8.1 Merial Company Information
  45. 7.8.2 Merial Business Overview
  46. 7.8.3 Merial Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merial Animal Antibacterial and Antibiotics Product Portfolio
  48. 7.8.5 Merial Recent Developments
  49. 7.9 Neogen
  50. 7.9.1 Neogen Company Information
  51. 7.9.2 Neogen Business Overview
  52. 7.9.3 Neogen Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Neogen Animal Antibacterial and Antibiotics Product Portfolio
  54. 7.9.5 Neogen Recent Developments
  55. 7.10 Norbrook
  56. 7.10.1 Norbrook Company Information
  57. 7.10.2 Norbrook Business Overview
  58. 7.10.3 Norbrook Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Norbrook Animal Antibacterial and Antibiotics Product Portfolio
  60. 7.10.5 Norbrook Recent Developments
  61. 7.11 Orion
  62. 7.11.1 Orion Company Information
  63. 7.11.2 Orion Business Overview
  64. 7.11.3 Orion Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Orion Animal Antibacterial and Antibiotics Product Portfolio
  66. 7.11.5 Orion Recent Developments
  67. 7.12 Phibro Animal Health
  68. 7.12.1 Phibro Animal Health Company Information
  69. 7.12.2 Phibro Animal Health Business Overview
  70. 7.12.3 Phibro Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Phibro Animal Health Animal Antibacterial and Antibiotics Product Portfolio
  72. 7.12.5 Phibro Animal Health Recent Developments
  73. 7.13 Vétoquinol
  74. 7.13.1 Vétoquinol Company Information
  75. 7.13.2 Vétoquinol Business Overview
  76. 7.13.3 Vétoquinol Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vétoquinol Animal Antibacterial and Antibiotics Product Portfolio
  78. 7.13.5 Vétoquinol Recent Developments
  79. 7.14 Virbac
  80. 7.14.1 Virbac Company Information
  81. 7.14.2 Virbac Business Overview
  82. 7.14.3 Virbac Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Virbac Animal Antibacterial and Antibiotics Product Portfolio
  84. 7.14.5 Virbac Recent Developments
  85. 7.15 Vitafor
  86. 7.15.1 Vitafor Company Information
  87. 7.15.2 Vitafor Business Overview
  88. 7.15.3 Vitafor Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Vitafor Animal Antibacterial and Antibiotics Product Portfolio
  90. 7.15.5 Vitafor Recent Developments
  91. 7.16 Bayer HealthCare
  92. 7.16.1 Bayer HealthCare Company Information
  93. 7.16.2 Bayer HealthCare Business Overview
  94. 7.16.3 Bayer HealthCare Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Bayer HealthCare Animal Antibacterial and Antibiotics Product Portfolio
  96. 7.16.5 Bayer HealthCare Recent Developments
  97. 7.17 Merck Animal Health
  98. 7.17.1 Merck Animal Health Company Information
  99. 7.17.2 Merck Animal Health Business Overview
  100. 7.17.3 Merck Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Merck Animal Health Animal Antibacterial and Antibiotics Product Portfolio
  102. 7.17.5 Merck Animal Health Recent Developments
  103. 7.18 Zoetis
  104. 7.18.1 Zoetis Company Information
  105. 7.18.2 Zoetis Business Overview
  106. 7.18.3 Zoetis Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Zoetis Animal Antibacterial and Antibiotics Product Portfolio
  108. 7.18.5 Zoetis Recent Developments
8 North America
  1. 8.1 North America Animal Antibacterial and Antibiotics Revenue (2021-2032)
  2. 8.2 North America Animal Antibacterial and Antibiotics Revenue by Type (2021-2032)
  3. 8.2.1 North America Animal Antibacterial and Antibiotics Revenue by Type (2021-2026)
  4. 8.2.2 North America Animal Antibacterial and Antibiotics Revenue by Type (2027-2032)
  5. 8.3 North America Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032)
  6. 8.4 North America Animal Antibacterial and Antibiotics Revenue by Application (2021-2032)
  7. 8.4.1 North America Animal Antibacterial and Antibiotics Revenue by Application (2021-2026)
  8. 8.4.2 North America Animal Antibacterial and Antibiotics Revenue by Application (2027-2032)
  9. 8.5 North America Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032)
  10. 8.6 North America Animal Antibacterial and Antibiotics Revenue by Country
  11. 8.6.1 North America Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Animal Antibacterial and Antibiotics Revenue by Country (2021-2026)
  13. 8.6.3 North America Animal Antibacterial and Antibiotics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Animal Antibacterial and Antibiotics Revenue (2021-2032)
  2. 9.2 Europe Animal Antibacterial and Antibiotics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Animal Antibacterial and Antibiotics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Animal Antibacterial and Antibiotics Revenue by Type (2027-2032)
  5. 9.3 Europe Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Animal Antibacterial and Antibiotics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Animal Antibacterial and Antibiotics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Animal Antibacterial and Antibiotics Revenue by Application (2027-2032)
  9. 9.5 Europe Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Animal Antibacterial and Antibiotics Revenue by Country
  11. 9.6.1 Europe Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Animal Antibacterial and Antibiotics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Animal Antibacterial and Antibiotics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Animal Antibacterial and Antibiotics Revenue (2021-2032)
  2. 10.2 China Animal Antibacterial and Antibiotics Revenue by Type (2021-2032)
  3. 10.2.1 China Animal Antibacterial and Antibiotics Revenue by Type (2021-2026)
  4. 10.2.2 China Animal Antibacterial and Antibiotics Revenue by Type (2027-2032)
  5. 10.3 China Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032)
  6. 10.4 China Animal Antibacterial and Antibiotics Revenue by Application (2021-2032)
  7. 10.4.1 China Animal Antibacterial and Antibiotics Revenue by Application (2021-2026)
  8. 10.4.2 China Animal Antibacterial and Antibiotics Revenue by Application (2027-2032)
  9. 10.5 China Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Antibacterial and Antibiotics Revenue (2021-2032)
  2. 11.2 Asia Animal Antibacterial and Antibiotics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Animal Antibacterial and Antibiotics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Animal Antibacterial and Antibiotics Revenue by Type (2027-2032)
  5. 11.3 Asia Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Animal Antibacterial and Antibiotics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Animal Antibacterial and Antibiotics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Animal Antibacterial and Antibiotics Revenue by Application (2027-2032)
  9. 11.5 Asia Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Animal Antibacterial and Antibiotics Revenue by Country
  11. 11.6.1 Asia Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Animal Antibacterial and Antibiotics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Animal Antibacterial and Antibiotics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Antibacterial and Antibiotics Revenue (2021-2032)
  2. 12.2 SAMEA Animal Antibacterial and Antibiotics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Animal Antibacterial and Antibiotics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Animal Antibacterial and Antibiotics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Animal Antibacterial and Antibiotics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Animal Antibacterial and Antibiotics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Animal Antibacterial and Antibiotics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Animal Antibacterial and Antibiotics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Animal Antibacterial and Antibiotics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Animal Antibacterial and Antibiotics Revenue by Country
  11. 12.6.1 SAMEA Animal Antibacterial and Antibiotics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Animal Antibacterial and Antibiotics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Animal Antibacterial and Antibiotics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst